tumor-pulsed dendritic cells Report issue

Vaccine Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

autologous dendritic cell cancer vaccine | autologous dendritic cells loaded with autologous tumor rna | autologous dendritic cells loaded with autologous tumour homogenate | autologous dendritic cells pulsed with tumor lysate antigen vaccine | autologous dendritic cell-tumor cell | autologous dendritic cell vaccine | autologous tumor lysate, particle-loaded, dendritic cells | autologous tumor lysate-pulsed dendritic cells | cancer stem cell stimulated dendritic cells | dendritic cell-based tumor vaccine | dendritic cells pulsed with tumor lysate | dendritic cell vaccine | leukemic dendritic cell vaccine | malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine | personalized mature dendritic cell vaccine | tumor antigen loaded autologous dendritic cells | tumor antigen-loaded dendritic cell-derived exosomes | tumor lysate-loaded autologous dendritic cells | tumor lysate, particle loaded, dendritic cells | tumor lysate-pulsed autologous dendritic cell vaccine | tumor lysate-pulsed dendritic cells | tumor-lysate pulsed dendritic cells | tumor lysate-pulsed dendritic cell vaccine | tumor peptide-loaded myeloid dendritic cells | tumor peptide-loaded plasmacytoid dendritic cells | tumor-pulsed dendritic cells

Organizations (66)

Research & Development (66)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (43)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (43)


 

Astrocytoma (Phase 2)

Biliary Tract Neoplasms (Phase 1/Phase 2)

Brain Neoplasms (Phase 3)

Breast Neoplasms (Phase 2)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 1/Phase 2)

Chemotherapy, Adjuvant (Phase 2)

Colorectal Neoplasms (Phase 2)

Dendritic Cells (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Glioblastoma (Phase 3)

Glioma (Phase 3)

Gliosarcoma (Phase 2)

Hamartoma (Phase 2)

HIV (Phase 1)

HIV Infections (Phase 1/Phase 2)

Leukemia (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Melanoma (Phase 3)

Mesothelioma, Malignant (Phase 1/Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2/Phase 3)

Neoplasms, Connective and Soft Tissue (Phase 1/Phase 2)

Neuroblastoma (Phase 2)

Oligodendroglioma (Phase 2)

Osteosarcoma (Phase 1)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2/Phase 3)

Prostatic Neoplasms (Phase 3)

Rhabdomyosarcoma (Phase 1)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 1)

Sarcoma, Synovial (Phase 1)

Sepsis (Phase 2)

Sezary Syndrome (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Stomach Neoplasms (Phase 2)

Vaccination (Phase 2)

Wilms Tumor (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 64
  • # of Trial Organizations: 66

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue